Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.07T -1.1%
Revenue (ttm)	1.68T +0.3%
Net Income	59.24B -68.7%
EPS	4,500.58 -66.9%
Shares Out	13.18M
PE Ratio	18.11
Forward PE	16.09
Dividend	1,100.00 (1.20%)
Ex-Dividend Date	n/a

Volume	72,762
Average Volume	50,898
Open	89,400
Previous Close	91,500
Day's Range	80,300 - 89,500
52-Week Range	70,900 - 106,800
Beta	0.37
RSI	33.50
Earnings Date	Mar 18, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,253
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.